Xingwen Han

456 total citations
15 papers, 341 citations indexed

About

Xingwen Han is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Xingwen Han has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Rheumatology. Recurrent topics in Xingwen Han's work include MicroRNA in disease regulation (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Bone Tissue Engineering Materials (3 papers). Xingwen Han is often cited by papers focused on MicroRNA in disease regulation (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Bone Tissue Engineering Materials (3 papers). Xingwen Han collaborates with scholars based in China and United States. Xingwen Han's co-authors include Wenji Wang, Peng Qu, Tong Zhao, Xueliang Zhang, Guangjie Li, Yongping Wang, Haiyan Zhao, Jingjing He, Lei Jiang and Xun� Li and has published in prestigious journals such as Journal of Cellular Physiology, Arthroscopy The Journal of Arthroscopic and Related Surgery and Journal of Cellular and Molecular Medicine.

In The Last Decade

Xingwen Han

14 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingwen Han China	9	235	167	44	42	34	15	341
Tuan‐Hui Chen China	2	246 1.0×	121 0.7×	43 1.0×	23 0.5×	22 0.6×	2	338
Ben Wu China	5	226 1.0×	99 0.6×	46 1.0×	35 0.8×	35 1.0×	7	339
Yuanmin Zhang China	11	264 1.1×	159 1.0×	41 0.9×	72 1.7×	21 0.6×	24	411
Zepeng Su China	10	198 0.8×	78 0.5×	30 0.7×	45 1.1×	55 1.6×	24	333
Uma Thanigai Arasu Finland	11	358 1.5×	151 0.9×	39 0.9×	32 0.8×	20 0.6×	13	467
Jungmi Lee South Korea	7	233 1.0×	92 0.6×	42 1.0×	51 1.2×	27 0.8×	11	389
Boer Li China	9	211 0.9×	80 0.5×	49 1.1×	25 0.6×	35 1.0×	12	328
Hanji Huang China	7	170 0.7×	72 0.4×	33 0.8×	90 2.1×	40 1.2×	15	283
Xueyang Liao China	11	261 1.1×	55 0.3×	47 1.1×	53 1.3×	35 1.0×	14	380

Countries citing papers authored by Xingwen Han

Since Specialization

Citations

This map shows the geographic impact of Xingwen Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwen Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwen Han more than expected).

Fields of papers citing papers by Xingwen Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwen Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwen Han. The network helps show where Xingwen Han may publish in the future.

Co-authorship network of co-authors of Xingwen Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwen Han. A scholar is included among the top collaborators of Xingwen Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwen Han. Xingwen Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Han, Xingwen, Jingjing He, Zhan Wang, et al.. (2022). Monooxygenase DBH like 1 knockdown suppresses the proliferation and xenograft tumor growth of osteosarcoma cells via inducing apoptosis. Panminerva Medica. 67(4). 259–260. 1 indexed citations

Wang, Zhan, et al.. (2022). Treatment of Traumatic Cartilage Defects of Rabbit Knee Joint by Adipose Derived Stem Cells Combined with Kartogenin Hydroxyapatite Nano-Microsphere Complex. Journal of Biomedical Nanotechnology. 18(1). 61–76. 5 indexed citations

Zhang, Xueliang, Wenji Wang, Yongping Wang, et al.. (2021). Extracellular Vesicle-Encapsulated miR-29b-3p Released From Bone Marrow-Derived Mesenchymal Stem Cells Underpins Osteogenic Differentiation. Frontiers in Cell and Developmental Biology. 8. 581545–581545. 34 indexed citations

Wang, Zhan, Xingwen Han, & Wenji Wang. (2021). Regarding “Intra‐Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials”. Arthroscopy The Journal of Arthroscopic and Related Surgery. 37(12). 3390–3391.

Han, Xingwen, Jingjing He, Zhan Wang, et al.. (2021). Fabrication of silver nanoparticles/gelatin hydrogel system for bone regeneration and fracture treatment. Drug Delivery. 28(1). 319–324. 30 indexed citations

Li, Guangjie, et al.. (2020). Long non‐coding RNA‐H19 stimulates osteogenic differentiation of bone marrow mesenchymal stem cells via the microRNA‐149/ SDF‐1 axis. Journal of Cellular and Molecular Medicine. 24(9). 4944–4955. 37 indexed citations

Zhang, Xueliang, Yongping Wang, Haiyan Zhao, et al.. (2020). Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibition. Stem Cell Research & Therapy. 11(1). 227–227. 84 indexed citations

Wang, Wenji, Xingwen Han, Tong Zhao, et al.. (2020). AGT, targeted by miR-149-5p, promotes IL-6-induced inflammatory responses of chondrocytes in osteoarthritis via activating JAK2/STAT3 pathway.. PubMed. 38(6). 1088–1095. 26 indexed citations

He, Jingjing, Lingyi Zhang, Dan Guo, et al.. (2020). Sinomenium Inhibits the Viability of Hepatoma Carcinoma Cells through Activating IFNA2. ONCOLOGIE. 22(1). 1–12. 1 indexed citations

10.

Cao, Wei, Zhan Wang, Xingwen Han, Jianhua Liu, & Wenji Wang. (2019). In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2. Bioorganic & Medicinal Chemistry Letters. 29(20). 126665–126665. 8 indexed citations

11.

Zhao, Haiyan, et al.. (2019). Enhanced Bone Regeneration and Bone Defect Repair Using Magnesium/Lithium-Co-Modified, Porous, Hydroxyapatite Composite Scaffolds. Science of Advanced Materials. 12(1). 124–136. 3 indexed citations

12.

Han, Xingwen, Wenji Wang, Jingjing He, Lei Jiang, & Xun� Li. (2019). Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review). Oncology Letters. 17(3). 2592–2598. 48 indexed citations

13.

Wang, Zhan, et al.. (2019). Long noncoding RNA PTENP1 affects the recovery of spinal cord injury by regulating the expression of miR‐19b and miR‐21. Journal of Cellular Physiology. 235(4). 3634–3645. 34 indexed citations

14.

Li, Guangjie, et al.. (2019). Hypermethylation of microRNA‐149 activates SDF‐1/CXCR4 to promote osteogenic differentiation of mesenchymal stem cells. Journal of Cellular Physiology. 234(12). 23485–23494. 23 indexed citations

15.

Zhang, Chao, et al.. (2016). Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.. PubMed. 17(8). 3785–91. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact